EFONIDIPINE HYDROCHLORIDE

Details

Stereochemistry	RACEMIC
Molecular Formula	C34H38N3O7P.ClH
Molecular Weight	668.116
Optical Activity	( + / - )
Defined Stereocenters	0 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

Cl.CC1=C(C(C2=CC=CC(=C2)[N+]([O-])=O)C(=C(C)N1)P3(=O)OCC(C)(C)CO3)C(=O)OCCN(CC4=CC=CC=C4)C5=CC=CC=C5

InChI

InChIKey=OXVTXPCIJDYQIS-UHFFFAOYSA-N

InChI=1S/C34H38N3O7P.ClH/c1-24-30(33(38)42-19-18-36(28-15-9-6-10-16-28)21-26-12-7-5-8-13-26)31(27-14-11-17-29(20-27)37(39)40)32(25(2)35-24)45(41)43-22-34(3,4)23-44-45;/h5-17,20,31,35H,18-19,21-23H2,1-4H3;1H

HIDE SMILES / InChI

Description
Sources: http://www.ncbi.nlm.nih.gov/pubmed/12070536

Efonidipine is a 1,4-dihydropyridine derivative for the treatment of hypertension and angina. Efonidipine exerts its antihypertensive and antianginal effects through blocking L- and T-type calcium channels.

Originator

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Voltage-gated T-type calcium channel 17 Target ID: CHEMBL2362995 Sources: http://www.ncbi.nlm.nih.gov/pubmed/12070536	Blocker 537		13.0 nM [IC50]
Voltage-gated L-type calcium channel 92 Target ID: CHEMBL2095229 Sources: http://www.ncbi.nlm.nih.gov/pubmed/12070536	Blocker 537

Conditions

Condition	Modality	Targets	Highest Phase	Product
Hypertension 567 Sources: http://www.ncbi.nlm.nih.gov/pubmed/21088755	Primary		Approved 8429	LANDEL Approved Use Unknown
Angina pectoris 106 Sources: http://www.ncbi.nlm.nih.gov/pubmed/21088755	Primary		Approved 8429	LANDEL Approved Use Unknown

PubMed

Title	Date	PubMed
Efonidipine hydrochloride: a dual blocker of L- and T-type ca(2+) channels.	2002 Winter	12070536

Sample Use Guides

In Vivo Use Guide

40 mg once daily for 12 weeks

Route of Administration: Oral

In Vitro Use Guide

Effects of efonidipine on isolated myocardial and aortic preparations was studied. The drug produced concentration-dependent negative chronotropic effects on isolated guinea-pig atrial preparations.The potency was 3.08 x 10(-8)M (EC30).

Name

Type

Language

EFONIDIPINE HYDROCHLORIDE

Common Name

English

Efonidipine hydrochloride [WHO-DD]

Common Name

English

EFONIDIPINE HYDROCHLORIDE [MI]

Common Name

English

3-PYRIDINECARBOXYLIC ACID, 5-(5,5-DIMETHYL-2-OXIDO-1,3,2-DIOXAPHOSPHORINAN-2-YL)-1,4-DIHYDRO-2,6-DIMETHYL-4-(3-NITROPHENYL)-, 2-(PHENYL(PHENYLMETHYL)AMINO)ETHYL ESTER, MONOHYDROCHLORIDE

Common Name

English

3-PYRIDINECARBOXYLIC ACID, 5-(5,5-DIMETHYL-1,3,2-DIOXAPHOSPHORINAN-2-YL)-1,4-DIHYDRO-2,6-DIMETHYL-4-(3-NITROPHENYL)-, 2-(PHENYL(PHENYLMETHYL)AMINO)ETHYL ESTER, P-OXIDE, MONOHYDROCHLORIDE

Common Name

English

EFONIDIPINE HYDROCHLORIDE [MART.]

Common Name

English

EFONIDIPINE HCL

Common Name

English

2-(N-BENZYLANILINO)ETHYL (±)-1,4-DIHYDRO-2,6-DIMETHYL-4-(M-NITROPHENYL)-5-PHOSPHONONICOTINATE, CYCLIC 2,2-DIMETHYLTRIMETHYLENE ESTER, HYDROCHLORIDE

Common Name

English

3-PYRIDINECARBOXYLIC ACID, 5-(5,5-DIMETHYL-2-OXIDO-1,3,2-DIOXAPHOSPHORINAN-2-YL)-1,4-DIHYDRO-2,6-DIMETHYL-4-(3-NITROPHENYL)-, 2-(PHENYL(PHENYLMETHYL)AMINO)ETHYL ESTER, HYDROCHLORIDE (1:1)

Systematic Name

English

Classification Tree Code System Code

NCI_THESAURUS

C333